 | • レポートコード：MRC308GR11518 • 出版社/出版日：GlobalInfoResearch / 2023年8月14日 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のホスホジエステラーゼ-4 阻害剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のホスホジエステラーゼ-4 阻害剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– ホスホジエステラーゼ-4 阻害剤の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
ホスホジエステラーゼ-4 阻害剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・経口、外用
用途別セグメント
・子供、大人
主要な市場プレーヤー
・Camber Pharmaceuticals、AstraZeneca、GSK、Arcutis Biotherapeutics、Amgen、Fosun-Pharmaceutical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、ホスホジエステラーゼ-4 阻害剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なホスホジエステラーゼ-4 阻害剤メーカーの企業概要、2019年～2022年までのホスホジエステラーゼ-4 阻害剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なホスホジエステラーゼ-4 阻害剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ホスホジエステラーゼ-4 阻害剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのホスホジエステラーゼ-4 阻害剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのホスホジエステラーゼ-4 阻害剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびホスホジエステラーゼ-4 阻害剤の産業チェーンを掲載しています。
・第14、15章では、ホスホジエステラーゼ-4 阻害剤の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– ホスホジエステラーゼ-4 阻害剤の概要
– 種類別分析（2018年vs2022年vs2029年）：経口、外用
– 用途別分析（2018年vs2022年vs2029年）：子供、大人
– 世界のホスホジエステラーゼ-4 阻害剤市場規模・予測
– 世界のホスホジエステラーゼ-4 阻害剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Camber Pharmaceuticals、AstraZeneca、GSK、Arcutis Biotherapeutics、Amgen、Fosun-Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：経口、外用
・用途別分析2018年-2029年：子供、大人
・ホスホジエステラーゼ-4 阻害剤の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ホスホジエステラーゼ-4 阻害剤のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ホスホジエステラーゼ-4 阻害剤のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ホスホジエステラーゼ-4 阻害剤の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ホスホジエステラーゼ-4 阻害剤の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Phosphodiesterase-4 Inhibitor
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Phosphodiesterase-4 Inhibitor Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 External Use
1.4 Market Analysis by Application
1.4.1 Overview: Global Phosphodiesterase-4 Inhibitor Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Children
1.4.3 Adults
1.5 Global Phosphodiesterase-4 Inhibitor Market Size & Forecast
1.5.1 Global Phosphodiesterase-4 Inhibitor Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Phosphodiesterase-4 Inhibitor Sales Quantity (2018-2029)
1.5.3 Global Phosphodiesterase-4 Inhibitor Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Camber Pharmaceuticals
2.1.1 Camber Pharmaceuticals Details
2.1.2 Camber Pharmaceuticals Major Business
2.1.3 Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Product and Services
2.1.4 Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Camber Pharmaceuticals Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Phosphodiesterase-4 Inhibitor Product and Services
2.2.4 AstraZeneca Phosphodiesterase-4 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Phosphodiesterase-4 Inhibitor Product and Services
2.3.4 GSK Phosphodiesterase-4 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Arcutis Biotherapeutics
2.4.1 Arcutis Biotherapeutics Details
2.4.2 Arcutis Biotherapeutics Major Business
2.4.3 Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Product and Services
2.4.4 Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Arcutis Biotherapeutics Recent Developments/Updates
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Phosphodiesterase-4 Inhibitor Product and Services
2.5.4 Amgen Phosphodiesterase-4 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Amgen Recent Developments/Updates
2.6 Fosun-Pharmaceutical
2.6.1 Fosun-Pharmaceutical Details
2.6.2 Fosun-Pharmaceutical Major Business
2.6.3 Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Product and Services
2.6.4 Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Fosun-Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Phosphodiesterase-4 Inhibitor by Manufacturer
3.1 Global Phosphodiesterase-4 Inhibitor Sales Quantity by Manufacturer (2018-2023)
3.2 Global Phosphodiesterase-4 Inhibitor Revenue by Manufacturer (2018-2023)
3.3 Global Phosphodiesterase-4 Inhibitor Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Phosphodiesterase-4 Inhibitor by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Phosphodiesterase-4 Inhibitor Manufacturer Market Share in 2022
3.4.2 Top 6 Phosphodiesterase-4 Inhibitor Manufacturer Market Share in 2022
3.5 Phosphodiesterase-4 Inhibitor Market: Overall Company Footprint Analysis
3.5.1 Phosphodiesterase-4 Inhibitor Market: Region Footprint
3.5.2 Phosphodiesterase-4 Inhibitor Market: Company Product Type Footprint
3.5.3 Phosphodiesterase-4 Inhibitor Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Phosphodiesterase-4 Inhibitor Market Size by Region
4.1.1 Global Phosphodiesterase-4 Inhibitor Sales Quantity by Region (2018-2029)
4.1.2 Global Phosphodiesterase-4 Inhibitor Consumption Value by Region (2018-2029)
4.1.3 Global Phosphodiesterase-4 Inhibitor Average Price by Region (2018-2029)
4.2 North America Phosphodiesterase-4 Inhibitor Consumption Value (2018-2029)
4.3 Europe Phosphodiesterase-4 Inhibitor Consumption Value (2018-2029)
4.4 Asia-Pacific Phosphodiesterase-4 Inhibitor Consumption Value (2018-2029)
4.5 South America Phosphodiesterase-4 Inhibitor Consumption Value (2018-2029)
4.6 Middle East and Africa Phosphodiesterase-4 Inhibitor Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2029)
5.2 Global Phosphodiesterase-4 Inhibitor Consumption Value by Type (2018-2029)
5.3 Global Phosphodiesterase-4 Inhibitor Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2029)
6.2 Global Phosphodiesterase-4 Inhibitor Consumption Value by Application (2018-2029)
6.3 Global Phosphodiesterase-4 Inhibitor Average Price by Application (2018-2029)
7 North America
7.1 North America Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2029)
7.2 North America Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2029)
7.3 North America Phosphodiesterase-4 Inhibitor Market Size by Country
7.3.1 North America Phosphodiesterase-4 Inhibitor Sales Quantity by Country (2018-2029)
7.3.2 North America Phosphodiesterase-4 Inhibitor Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2029)
8.2 Europe Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2029)
8.3 Europe Phosphodiesterase-4 Inhibitor Market Size by Country
8.3.1 Europe Phosphodiesterase-4 Inhibitor Sales Quantity by Country (2018-2029)
8.3.2 Europe Phosphodiesterase-4 Inhibitor Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Phosphodiesterase-4 Inhibitor Market Size by Region
9.3.1 Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Phosphodiesterase-4 Inhibitor Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2029)
10.2 South America Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2029)
10.3 South America Phosphodiesterase-4 Inhibitor Market Size by Country
10.3.1 South America Phosphodiesterase-4 Inhibitor Sales Quantity by Country (2018-2029)
10.3.2 South America Phosphodiesterase-4 Inhibitor Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Phosphodiesterase-4 Inhibitor Market Size by Country
11.3.1 Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Phosphodiesterase-4 Inhibitor Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Phosphodiesterase-4 Inhibitor Market Drivers
12.2 Phosphodiesterase-4 Inhibitor Market Restraints
12.3 Phosphodiesterase-4 Inhibitor Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Phosphodiesterase-4 Inhibitor and Key Manufacturers
13.2 Manufacturing Costs Percentage of Phosphodiesterase-4 Inhibitor
13.3 Phosphodiesterase-4 Inhibitor Production Process
13.4 Phosphodiesterase-4 Inhibitor Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Phosphodiesterase-4 Inhibitor Typical Distributors
14.3 Phosphodiesterase-4 Inhibitor Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Phosphodiesterase-4 Inhibitor Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Phosphodiesterase-4 Inhibitor Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Camber Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Camber Pharmaceuticals Major Business
Table 5. Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Product and Services
Table 6. Camber Pharmaceuticals Phosphodiesterase-4 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Camber Pharmaceuticals Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Phosphodiesterase-4 Inhibitor Product and Services
Table 11. AstraZeneca Phosphodiesterase-4 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Phosphodiesterase-4 Inhibitor Product and Services
Table 16. GSK Phosphodiesterase-4 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Arcutis Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 19. Arcutis Biotherapeutics Major Business
Table 20. Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Product and Services
Table 21. Arcutis Biotherapeutics Phosphodiesterase-4 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Arcutis Biotherapeutics Recent Developments/Updates
Table 23. Amgen Basic Information, Manufacturing Base and Competitors
Table 24. Amgen Major Business
Table 25. Amgen Phosphodiesterase-4 Inhibitor Product and Services
Table 26. Amgen Phosphodiesterase-4 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Amgen Recent Developments/Updates
Table 28. Fosun-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Fosun-Pharmaceutical Major Business
Table 30. Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Product and Services
Table 31. Fosun-Pharmaceutical Phosphodiesterase-4 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Fosun-Pharmaceutical Recent Developments/Updates
Table 33. Global Phosphodiesterase-4 Inhibitor Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Phosphodiesterase-4 Inhibitor Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Phosphodiesterase-4 Inhibitor Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in Phosphodiesterase-4 Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Phosphodiesterase-4 Inhibitor Production Site of Key Manufacturer
Table 38. Phosphodiesterase-4 Inhibitor Market: Company Product Type Footprint
Table 39. Phosphodiesterase-4 Inhibitor Market: Company Product Application Footprint
Table 40. Phosphodiesterase-4 Inhibitor New Market Entrants and Barriers to Market Entry
Table 41. Phosphodiesterase-4 Inhibitor Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Phosphodiesterase-4 Inhibitor Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Phosphodiesterase-4 Inhibitor Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Phosphodiesterase-4 Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Phosphodiesterase-4 Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Phosphodiesterase-4 Inhibitor Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global Phosphodiesterase-4 Inhibitor Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Phosphodiesterase-4 Inhibitor Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Phosphodiesterase-4 Inhibitor Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Phosphodiesterase-4 Inhibitor Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global Phosphodiesterase-4 Inhibitor Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Phosphodiesterase-4 Inhibitor Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Phosphodiesterase-4 Inhibitor Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Phosphodiesterase-4 Inhibitor Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global Phosphodiesterase-4 Inhibitor Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Phosphodiesterase-4 Inhibitor Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Phosphodiesterase-4 Inhibitor Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Phosphodiesterase-4 Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Phosphodiesterase-4 Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Phosphodiesterase-4 Inhibitor Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Phosphodiesterase-4 Inhibitor Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Phosphodiesterase-4 Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Phosphodiesterase-4 Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Phosphodiesterase-4 Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Phosphodiesterase-4 Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Phosphodiesterase-4 Inhibitor Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Phosphodiesterase-4 Inhibitor Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Phosphodiesterase-4 Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Phosphodiesterase-4 Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Phosphodiesterase-4 Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Phosphodiesterase-4 Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Phosphodiesterase-4 Inhibitor Raw Material
Table 101. Key Manufacturers of Phosphodiesterase-4 Inhibitor Raw Materials
Table 102. Phosphodiesterase-4 Inhibitor Typical Distributors
Table 103. Phosphodiesterase-4 Inhibitor Typical Customers
List of Figures
Figure 1. Phosphodiesterase-4 Inhibitor Picture
Figure 2. Global Phosphodiesterase-4 Inhibitor Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Phosphodiesterase-4 Inhibitor Consumption Value Market Share by Type in 2022
Figure 4. Oral Examples
Figure 5. External Use Examples
Figure 6. Global Phosphodiesterase-4 Inhibitor Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Phosphodiesterase-4 Inhibitor Consumption Value Market Share by Application in 2022
Figure 8. Children Examples
Figure 9. Adults Examples
Figure 10. Global Phosphodiesterase-4 Inhibitor Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Phosphodiesterase-4 Inhibitor Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Phosphodiesterase-4 Inhibitor Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Phosphodiesterase-4 Inhibitor Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Phosphodiesterase-4 Inhibitor Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Phosphodiesterase-4 Inhibitor by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Phosphodiesterase-4 Inhibitor Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Phosphodiesterase-4 Inhibitor Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Phosphodiesterase-4 Inhibitor Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Phosphodiesterase-4 Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Phosphodiesterase-4 Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Phosphodiesterase-4 Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Phosphodiesterase-4 Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Phosphodiesterase-4 Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Phosphodiesterase-4 Inhibitor Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Phosphodiesterase-4 Inhibitor Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Phosphodiesterase-4 Inhibitor Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Phosphodiesterase-4 Inhibitor Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Phosphodiesterase-4 Inhibitor Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Phosphodiesterase-4 Inhibitor Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Phosphodiesterase-4 Inhibitor Consumption Value Market Share by Region (2018-2029)
Figure 52. China Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Phosphodiesterase-4 Inhibitor Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Phosphodiesterase-4 Inhibitor Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Phosphodiesterase-4 Inhibitor Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Phosphodiesterase-4 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Phosphodiesterase-4 Inhibitor Market Drivers
Figure 73. Phosphodiesterase-4 Inhibitor Market Restraints
Figure 74. Phosphodiesterase-4 Inhibitor Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Phosphodiesterase-4 Inhibitor in 2022
Figure 77. Manufacturing Process Analysis of Phosphodiesterase-4 Inhibitor
Figure 78. Phosphodiesterase-4 Inhibitor Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source